Delivery Order SPE2DR25D3016-SPE2DR26FG5MC
Award Date 3/9/26
Potential Completion Date 3/30/26
Potential Value $63K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $128,188.50 firm fixed-price delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Ocrevus 300 mg/10 mL vials. The order is placed against the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is March 24, 2026.
- The Defense Logistics Agency issued a $76,913.10 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Ocrevus (ocrelizumab) 300 mg/10 mL vials. The order is firm fixed price with an ultimate completion date of March 30, 2026, and place of performance in Conshohocken, PA. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a $999,999,999 vehicle through December 2026 that covers pharmaceutical products and medical supplies for military...
- <p>The Defense Logistics Agency issued a $38,456.55 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for Ocrevus 300 mg/10 mL vial (10 mL) under a firm fixed-price contract. Ultimate completion date is March 20, 2026. Place of performance is Conshohocken, PA.</p>
- The Defense Logistics Agency awarded a $76,913.10 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price contract with a completion date of February 23, 2026, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- The Defense Logistics Agency awarded a $51,275.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This competitive award with no set-aside designation is scheduled for completion by February 19, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 26, 2026, with a ceiling value of $76,913.10 for OCREVUS 300 mg/10 mL vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC held by parent company Cencora, Inc., valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries an ultimate completion date of March 19, 2026 and is priced on a firm fixed-price basis.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Ocrevus 300 mg/10 mL vials with a ceiling value of $76,913.10.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 19, 2026, and is priced on a firm fixed-price basis.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ocrevus 300 mg/10 mL vials with a ceiling value of $120,192.80 and a firm fixed price structure. The order is scheduled for completion by October 14, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ocrevus 300 mg/10 mL vials valued at $32,694.46 under a firm fixed-price contract. The delivery order is non-set-aside and competitively awarded, with a completion date of June 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- <p>The Defense Logistics Agency issued a $76,913.10 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Ocrevus 300 mg/10 ml vials under a firm fixed-price arrangement with an ultimate completion date of March 26, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued without a set-aside.</p>